Martina E. Spehlmann

Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial

Stephan R. Targan, Brian G. Feagan, Richard N. Fedorak et al. · Gastroenterology · 2007 · 611 citations

Systemic Treatment, Immunology, Clinical Trials +6

Twin Study Indicates Loss of Interaction Between Microbiota and Mucosa of Patients With Ulcerative Colitis

Patricia Lepage, Robert Häsler, Martina E. Spehlmann et al. · Gastroenterology · 2011 · 583 citations · Full text

Chronic Inflammatory Diseases, Dysbiosis, Mucosal Immunology +11

Heart Failure is Associated with Depletion of Core Intestinal Microbiota

Mark Luedde, Thorben Winkler, Femke‐Anouska Heinsen et al. · ESC Heart Failure · 2017 · 306 citations · Full text

Absence of RNase H2 triggers generation of immunogenic micronuclei removed by autophagy

Kareen Bartsch, Katharina Knittler, Christopher Borowski et al. · Human Molecular Genetics · 2017 · 189 citations · Full text

Mitophagy, Immunology, Immune System +17

Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study

Martina E. Spehlmann, Alexander Z. Begun, Jens Burghardt et al. · Inflammatory Bowel Diseases · 2008 · 181 citations · Full text